careers indications treatment resistant cancerous tumors glioblastoma multiforme pancreatic cancer brain metastases technology technology overview scientific papers scientific conferences product pipeline overview trans sodium crocetinate tsc clinical trial results glioblastoma program pancreatic cancer program brain metastases program investor relations investor overview news releases presentations stock information sec filings corporate governance management board of directors email alerts contact us contact about company overview management team board of directors scientific advisory board intellectual property careers indications treatment resistant cancerous tumors glioblastoma multiforme pancreatic cancer brain metastases technology technology overview scientific papers scientific conferences product pipeline overview trans sodium crocetinate tsc clinical trial results glioblastoma program pancreatic cancer program brain metastases program investor relations investor overview news releases presentations stock information sec filings corporate governance management board of directors email alerts contact us contact aboutdiffusion pharmaceuticals is a clinical stage biotechnology company focused on improving the results of cancer treatments such as radiation therapy and chemotherapy in treatment resistant solid tumors including multiple fda orphan designated indications . learn more technologytsc modifies the tumor micro environment allowing enhanced therapeutic effects from radiation therapy and chemotherapy without the addition of harmful side effects . learn more indicationsdiffusion pharmaceuticals is dedicated to extending the life expectancy of patients with treatment resistant cancerous tumors including gbm pancreatic cancer and brain metastases . learn more product pipeline diffusion pharmaceuticals is developing tsc for the improved treatment of life threatening cancers in which tumor hypoxia oxygen deprivation diminishes the effectiveness of radiation therapy and chemotherapy . learn more watch diffusion pharmaceuticals inc. overview video with ceo david kalergis recent news 29 september 2016diffusion pharmaceuticals establishes scientific advisory board19 september 2016diffusion pharmaceuticals successfully completes animal toxicity studies in preparation for phase 3 pivotal trial of tsc in new diagnosed glioblastoma patients09 september 2016diffusion pharmaceuticals to present at 18th annual rodman & renshaw global investment conference18 august 2016diffusion pharmaceuticals announces reverse stock split in preparation for proposed uplisting to nasdaq capital market get the latests news first . subscribe to our newsletter . media click to open pdf in new window right click to download view2 likesdiffusion pharmaceuticals announces publication of tsc phase 1 2 glioblastoma multiforme trial data in the journal of neurosurgery view3 likesthe life science report diffusion pharmaceuticals takes aim at brain cancer 2015diffusionpharmaceuticals . all rights reserved . privacy policy disclaimer sitemap contact